Aboca is awarded for it's innovation by the Spanish press for the third consecutive year.

After winning prizes for the medical devices Melilax (2014) and NeoBianacid (2015), Aboca wins the Las mejores iniciativas en la farmacia (“Best Pharmacy Initiatives”) awarded again in the Investigación, Farmacologia y Productos (“Research, Pharmacology and Products”) category with the medical device NeoFitoroid.

The award was announced by Correo Farmaceutico, the eminent Spanish magazine for pharmacists, and was presented on Monday 4 April at the Canal Theatre in Madrid during an event attended by the Secretary General of the Ministry of Health, Javier Castrodeza and more than 600 people representing the most known companies and the most important associations and public authorities in the world of Spanish health.

“The award represents a new opportunity that recognises and confirms our company's innovative capacity for scientific research on complex vegetal substances” states Davide Mercati Aboca Media Relations Manager.

Aboca's participation in Expopharm 2017 has a dual purpose: to introduce the most recent breakthroughs in products...
Scientific research into complex vegetable substances, and the innovative understanding of the duality between natural...
The Aboca Group lands in Germany with the recent opening of Aboca Deutschland GmbH, headquartered in Mannheim in the...